Keyphrases
Hyperactivity
100%
Cognitive Functioning
100%
Methylphenidate
100%
Velocardiofacial Syndrome
100%
Placebo
25%
Attention Deficit Hyperactivity Disorder
16%
Cognitive Performance
16%
Clinically Significant
8%
Heart Rate
8%
Randomized Controlled Trial
8%
Primary Outcome Measure
8%
Blood Pressure
8%
Executive Function
8%
Continuous Performance Task
8%
Heart Blood
8%
Catechol-O-methyltransferase
8%
Treatment Discontinuation
8%
Follow-up Examination
8%
Attention-deficit Hyperactivity Disorder Symptoms
8%
Conners Rating Scales
8%
Stimulant Treatment
8%
Cardiovascular Evaluation
8%
Nursing and Health Professions
Methylphenidate
100%
Velocardiofacial Syndrome
100%
Hyperactivity
100%
Placebo
25%
Attention Deficit Disorder
25%
Adolescent
8%
Side Effect
8%
Blood Pressure
8%
Continuous Performance Test
8%
Executive Function Test
8%
Single Drug Dose
8%
Central Stimulant Agent
8%
Catechol
8%
Methyltransferase
8%
Rating Scale
8%
Medicine and Dentistry
Methylphenidate
100%
Hyperactivity
100%
Velocardiofacial Syndrome
100%
Placebo
25%
Attention Deficit Disorder
25%
Randomized Controlled Trial
8%
Blood Pressure
8%
Cardiovascular System
8%
Analeptic
8%
Side Effect
8%
Single Drug Dose
8%
Continuous Performance Test
8%
Methyltransferase
8%
Executive Function Test
8%
Rating Scale
8%
Psychology
Cognitive Functioning
100%
Methylphenidate
100%
Velocardiofacial Syndrome
100%
Attention Deficit Hyperactivity Disorder
25%
Cognitive Performance
16%
Performance Task
8%
Blood Pressure
8%
Conners Rating Scales
8%
Catechol-O-Methyltransferase
8%
Function Task
8%
Executive Function
8%
Pharmacology, Toxicology and Pharmaceutical Science
Hyperactivity
100%
Methylphenidate
100%
Velocardiofacial Syndrome
100%
Attention Deficit Disorder
25%
Placebo
25%
Side Effect
8%
Randomized Controlled Trial
8%
Methyltransferase
8%
Catechol
8%
Immunology and Microbiology
Blood Pressure
100%
Executive Function
100%